BioCentury
ARTICLE | Clinical News

Androgel testosterone gel: UMED began a Phase I pharmacokinetic trial

June 3, 1996 7:00 AM UTC

Unimed Pharmaceuticals Inc. (UMED), Buffalo Grove, Ill. Product: Androgel testosterone gel Indication: Hypogonadism Status: UMED began a Phase I pharmacokinetic trial in 8-10 men with hypogonadism (l...